CRISPR Therapeutics blueprints cell therapy manufacturing site; Regeneron fights back against kickback claims

SourceEndpoints News
Date Published06/25/2020
Author NameJohn Carroll
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name CRISPR Therapeutics
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):100
Year reshoring announced:2020
Domestically, the work will be done:In-house
Country(ies) from which reshored:Switzerland
City reshored to:Framingham
State(s) reshored to:MA
If relevant, work nearshored to:-
Product(s) reshoredcell therapy technologies
Find Reshoring Articles